• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较短时间和长时间[F]FDG-PET采集时间在巨细胞动脉炎中的诊断性能

Comparing Diagnostic Performance of Short and Long [F]FDG-PET Acquisition Times in Giant Cell Arteritis.

作者信息

Nienhuis Pieter H, van Nieuwland Marieke, van Praagh Gijs D, Markusiewicz Karolina, Colin Edgar M, van der Geest Kornelis S M, Wagenaar Nils, Brouwer Elisabeth, Alves Celina, Slart Riemer H J A

机构信息

University of Groningen, University Medical Center Groningen, Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, 9713 GZ Groningen, The Netherlands.

Hospital Group Twente, Department of Rheumatology and Clinical Immunology, 7600 SZ Almelo, The Netherlands.

出版信息

Diagnostics (Basel). 2023 Dec 27;14(1):62. doi: 10.3390/diagnostics14010062.

DOI:10.3390/diagnostics14010062
PMID:38201371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10802840/
Abstract

(1) Background: In giant cell arteritis (GCA), the assessment of cranial arteries using [F]fluorodeoxyglucose ([F]FDG) positron emission tomography (PET) combined with low-dose computed tomography (CT) may be challenging due to low image quality. This study aimed to investigate the effect of prolonged acquisition time on the diagnostic performance of [F]FDG PET/CT in GCA. (2) Methods: Patients with suspected GCA underwent [F]FDG-PET imaging with a short acquisition time (SAT) and long acquisition time (LAT). Two nuclear medicine physicians (NMPs) reported the presence or absence of GCA according to the overall image impression (gestalt) and total vascular score (TVS) of the cranial arteries. Inter-observer agreement and intra-observer agreement were assessed. (3) Results: In total, 38 patients were included, of whom 20 were diagnosed with GCA and 18 were without it. Sensitivity and specificity for GCA on SAT scans were 80% and 72%, respectively, for the first NMP, and 55% and 89% for the second NMP. On the LAT scans, these values were 65% and 83%, and 75% and 83%, respectively. When using the TVS, LAT scans showed especially increased specificity (94% for both NMPs). Observer agreement was higher on the LAT scans compared with that on the SAT scan. (4) Conclusions: LAT combined with the use of the TVS may decrease the number of false-positive assessments of [F]FDG PET/CT. Additionally, LAT and TVS may increase both inter and intra-observer agreement.

摘要

(1) 背景:在巨细胞动脉炎(GCA)中,由于图像质量较低,使用[F]氟脱氧葡萄糖([F]FDG)正电子发射断层扫描(PET)联合低剂量计算机断层扫描(CT)评估颅动脉可能具有挑战性。本研究旨在探讨延长采集时间对[F]FDG PET/CT在GCA诊断性能中的影响。(2) 方法:疑似GCA的患者接受了短采集时间(SAT)和长采集时间(LAT)的[F]FDG-PET成像。两名核医学医师(NMPs)根据颅动脉的整体图像印象(格式塔)和总血管评分(TVS)报告是否存在GCA。评估了观察者间一致性和观察者内一致性。(3) 结果:总共纳入38例患者,其中20例被诊断为GCA,18例未患GCA。对于第一位NMP,SAT扫描对GCA的敏感性和特异性分别为80%和72%,对于第二位NMP分别为55%和89%。在LAT扫描中,这些值分别为65%和83%,以及75%和83%。使用TVS时,LAT扫描显示特异性尤其增加(两位NMP均为94%)。与SAT扫描相比,LAT扫描的观察者一致性更高。(4) 结论:LAT结合TVS的使用可能会减少[F]FDG PET/CT假阳性评估的数量。此外,LAT和TVS可能会提高观察者间和观察者内的一致性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10802840/8fd13893b395/diagnostics-14-00062-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10802840/8a976364a4be/diagnostics-14-00062-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10802840/95eb17a23ac3/diagnostics-14-00062-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10802840/8c8bac424f90/diagnostics-14-00062-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10802840/8fd13893b395/diagnostics-14-00062-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10802840/8a976364a4be/diagnostics-14-00062-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10802840/95eb17a23ac3/diagnostics-14-00062-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10802840/8c8bac424f90/diagnostics-14-00062-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1075/10802840/8fd13893b395/diagnostics-14-00062-g004.jpg

相似文献

1
Comparing Diagnostic Performance of Short and Long [F]FDG-PET Acquisition Times in Giant Cell Arteritis.比较短时间和长时间[F]FDG-PET采集时间在巨细胞动脉炎中的诊断性能
Diagnostics (Basel). 2023 Dec 27;14(1):62. doi: 10.3390/diagnostics14010062.
2
Diagnostic performance of F-FDG PET-CT for large vessel involvement assessment in patients with suspected giant cell arteritis and negative temporal artery biopsy.18F-FDG PET-CT 对疑诊巨细胞动脉炎且颞动脉活检阴性患者大血管受累评估的诊断性能。
Ann Nucl Med. 2019 Jul;33(7):512-520. doi: 10.1007/s12149-019-01358-5. Epub 2019 Apr 11.
3
Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET/CT in giant cell arteritis.巨细胞动脉炎患者应用 FDG-PET/CT 进行颅动脉炎症的视觉和半定量评估。
Semin Arthritis Rheum. 2020 Aug;50(4):616-623. doi: 10.1016/j.semarthrit.2020.04.002. Epub 2020 Jun 2.
4
Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study.常规 18F-FDG PET/CT 对颅动脉炎症的简单二分法评估对巨细胞动脉炎的诊断具有很高的准确性:一项病例对照研究。
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):184-193. doi: 10.1007/s00259-018-4106-0. Epub 2018 Jul 31.
5
Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT.大血管血管炎:18F-FDG-PET/CT的观察者间一致性及诊断准确性
Biomed Res Int. 2015;2015:914692. doi: 10.1155/2015/914692. Epub 2015 Jan 28.
6
Usefulness of F-FDG PET-CT for assessing large-vessel involvement in patients with suspected giant cell arteritis and negative temporal artery biopsy.18F-FDG PET-CT 对于评估疑似巨细胞动脉炎且颞动脉活检阴性患者的大血管受累的作用。
Arthritis Res Ther. 2024 Jan 4;26(1):13. doi: 10.1186/s13075-023-03254-w.
7
Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.大剂量糖皮质激素治疗 3 天可减轻大动脉型巨细胞动脉炎患者 18F-FDG 摄取,但对诊断准确性的影响有限。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1119-1128. doi: 10.1007/s00259-018-4021-4. Epub 2018 Apr 18.
8
Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization.巨细胞动脉炎中 FDG PET/CT 的不同评分方法:标准化的必要性。
Medicine (Baltimore). 2015 Sep;94(37):e1542. doi: 10.1097/MD.0000000000001542.
9
Evaluation of baseline F-18 FDG positron emission tomography in the diagnosis and assessment of giant cell arteritis.评估 F-18 FDG 正电子发射断层扫描在巨细胞动脉炎诊断和评估中的作用。
Turk J Med Sci. 2024 Jan 5;54(1):69-75. doi: 10.55730/1300-0144.5767. eCollection 2024.
10
Diagnostic accuracy of ultrasound for detecting large-vessel giant cell arteritis using FDG PET/CT as the reference.超声检查对大血管巨细胞动脉炎的诊断准确性:以 FDG PET/CT 作为参考标准。
Rheumatology (Oxford). 2020 Aug 1;59(8):2062-2073. doi: 10.1093/rheumatology/kez568.

引用本文的文献

1
An in-depth comparison of vascular inflammation on ultrasound, FDG-PET/CT and MRI in patients with suspected giant cell arteritis.疑似巨细胞动脉炎患者血管炎症在超声、氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)及磁共振成像(MRI)上的深入比较
Eur J Nucl Med Mol Imaging. 2025 Feb 4. doi: 10.1007/s00259-025-07088-3.
2
What is new in imaging to assist in the diagnosis of giant cell arteritis and Takayasu's arteritis since the EULAR and ACR/VF recommendations?自欧洲抗风湿病联盟(EULAR)和美国风湿病学会/血管炎基金会(ACR/VF)发布相关建议以来,在用于辅助诊断巨细胞动脉炎和大动脉炎的影像学检查方面有哪些新进展?
Front Med (Lausanne). 2024 Oct 31;11:1495644. doi: 10.3389/fmed.2024.1495644. eCollection 2024.
3

本文引用的文献

1
Diagnostic delay in patients with giant cell arteritis: results of a fast-track clinic.巨细胞动脉炎患者的诊断延迟:快诊诊所的结果。
Clin Rheumatol. 2024 Jan;43(1):349-355. doi: 10.1007/s10067-023-06739-w. Epub 2023 Aug 31.
2
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update.EULAR 临床实践中应用影像学诊断大血管血管炎的推荐:2023 年更新版。
Ann Rheum Dis. 2024 May 15;83(6):741-751. doi: 10.1136/ard-2023-224543.
3
Giant cell arteritis with vertebral artery involvement-baseline characteristics and follow-up of a monocentric patient cohort.
Role and potential of F-fluorodeoxyglucose-positron emission tomography-computed tomography in large-vessel vasculitis: a comprehensive review.
氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在大血管血管炎中的作用及潜力:一项综述
Front Med (Lausanne). 2024 Aug 7;11:1432865. doi: 10.3389/fmed.2024.1432865. eCollection 2024.
4
The LEADING Guideline: Reporting Standards for Expert Panel, Best-Estimate Diagnosis, and Longitudinal Expert All Data (LEAD) Studies.《LEADING指南:专家小组、最佳估计诊断和纵向专家全数据(LEAD)研究的报告标准》
medRxiv. 2024 Sep 4:2024.03.19.24304526. doi: 10.1101/2024.03.19.24304526.
累及椎动脉的巨细胞动脉炎——单中心患者队列的基线特征及随访
Front Neurol. 2023 Jun 26;14:1188073. doi: 10.3389/fneur.2023.1188073. eCollection 2023.
4
Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis.巨细胞动脉炎中颅和大血管 PET/CT、超声和 MRI 联合检查的诊断效能:系统评价和荟萃分析。
Autoimmun Rev. 2023 Jul;22(7):103355. doi: 10.1016/j.autrev.2023.103355. Epub 2023 May 3.
5
Positron Emission Tomography (PET) Scan as a Diagnostic Tool for Giant Cell Arteritis.正电子发射断层扫描(PET)作为巨细胞动脉炎的诊断工具
Cureus. 2023 Mar 6;15(3):e35835. doi: 10.7759/cureus.35835. eCollection 2023 Mar.
6
Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study.症状发作到首次就诊的时间间隔较长可导致巨细胞动脉炎患者永久性视力丧失:一项队列研究。
RMD Open. 2023 Jan;9(1). doi: 10.1136/rmdopen-2022-002866.
7
2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis.2022年美国风湿病学会/欧洲抗风湿病联盟巨细胞动脉炎分类标准。
Arthritis Rheumatol. 2022 Dec;74(12):1881-1889. doi: 10.1002/art.42325. Epub 2022 Nov 8.
8
Distribution patterns of arterial affection and the influence of glucocorticoids on F-fluorodeoxyglucose positron emission tomography/CT in patients with giant cell arteritis.巨细胞动脉炎患者的动脉受累分布模式及糖皮质激素对 F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的影响。
RMD Open. 2022 Aug;8(2). doi: 10.1136/rmdopen-2022-002464.
9
PET/CT of cranial arteries for a sensitive diagnosis of giant cell arteritis.头部动脉 PET/CT 对巨细胞动脉炎的敏感诊断
Rheumatology (Oxford). 2023 Apr 3;62(4):1568-1575. doi: 10.1093/rheumatology/keac430.
10
Toward Reliable Uptake Metrics in Large Vessel Vasculitis Studies.迈向大血管血管炎研究中可靠的摄取指标。
Diagnostics (Basel). 2021 Oct 26;11(11):1986. doi: 10.3390/diagnostics11111986.